Autopsy report · NCT07453446

Clinical Study of U29 Injection (CD30-CART) in Patients With CD30-Positive Relapsed/Refractory Lymphoma

“The main consideration is the allocation of company resources, We can only terminate this research.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd

Sponsor type

Industry

Conditions

Relapsed or Refractory Lymphoma

Interventions

CD30 CAR-T Cells

Participants

0

Sites

1

Countries

China

Trials that died the same way

• A Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early AD
  “It has been made the strategic decision to terminate the study. This decision to terminate the study early is not being made for safety reasons.” (63% match in meaning)
• Evaluation of the Long-term Persistence of Hepatitis A Antibodies in Healthy Adults Who Were Vaccinated 21-25 Years Earlier With GlaxoSmithKline (GSK) Biologicals' Hepatitis A Vaccine, Havrix®
  “This study has been cancelled before initiation due to company's prioritisation decisions linked to resources restrictions.” (62% match in meaning)
• A Safety Study of PF-08046045/SGN-35T in Adults With Advanced Cancers
  “Study terminated as part of strategic considerations” (62% match in meaning)
• Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients in China
  “Based on the disclosed global research data on the same target drugs, the company has carefully considered and decided to terminate the project to optimize the existing research pipeline.” (61% match in meaning)
• Persona MC vs Attune Total Knee Replacement Study
  “Due to ongoing issues with recruitment, it was decided it was best to terminate the study and focus resources on other priorities.” (61% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.